MX2017008430A - Métodos para preparar derivados de 2,4-diaminopirimidina bíclica fusionada. - Google Patents

Métodos para preparar derivados de 2,4-diaminopirimidina bíclica fusionada.

Info

Publication number
MX2017008430A
MX2017008430A MX2017008430A MX2017008430A MX2017008430A MX 2017008430 A MX2017008430 A MX 2017008430A MX 2017008430 A MX2017008430 A MX 2017008430A MX 2017008430 A MX2017008430 A MX 2017008430A MX 2017008430 A MX2017008430 A MX 2017008430A
Authority
MX
Mexico
Prior art keywords
methods
fused bicyclic
preparing fused
diaminopyrimidine derivatives
diaminopyrimidine
Prior art date
Application number
MX2017008430A
Other languages
English (en)
Inventor
P Bakale Roger
P Allwein Shawn
E Petrillo Daniel
KLUWER Sander
R Mowrey Dale
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of MX2017008430A publication Critical patent/MX2017008430A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

La presente descripción está dirigida a métodos mejorados útiles para la preparación de, por ejemplo, 2-[[5-cloro-2-[[(6S)-6-[4-(2- hidroxietil)piperazina-1-il]-1-metoxi-6,7,8,9-tetrahidro-5Hbenzo[ 7]anuleno-2-il]amino]-irimidina-4-il]amino]-N-metil-benzamida (CEP-37440).
MX2017008430A 2014-12-23 2015-12-23 Métodos para preparar derivados de 2,4-diaminopirimidina bíclica fusionada. MX2017008430A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462095861P 2014-12-23 2014-12-23
PCT/US2015/000301 WO2016105529A1 (en) 2014-12-23 2015-12-23 Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives

Publications (1)

Publication Number Publication Date
MX2017008430A true MX2017008430A (es) 2018-03-23

Family

ID=55221488

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017008430A MX2017008430A (es) 2014-12-23 2015-12-23 Métodos para preparar derivados de 2,4-diaminopirimidina bíclica fusionada.

Country Status (9)

Country Link
US (1) US10259794B2 (es)
EP (1) EP3237408B1 (es)
JP (1) JP6849594B2 (es)
CA (1) CA2971415A1 (es)
ES (1) ES2707123T3 (es)
HK (1) HK1244789B (es)
IL (1) IL252945B (es)
MX (1) MX2017008430A (es)
WO (1) WO2016105529A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE027976T2 (en) * 2012-03-06 2016-11-28 Cephalon Inc Condensed ring bicyclic 2,4-diaminopyrimidine derivative as dual ALK and FAK inhibitor
EP2970205B1 (en) 2013-03-14 2019-05-08 Tolero Pharmaceuticals, Inc. Jak2 and alk2 inhibitors and methods for their use
JP2021524835A (ja) 2018-04-05 2021-09-16 スミトモ ダイニッポン ファーマ オンコロジー， インコーポレイテッド Ａｘｌキナーゼ阻害剤およびその使用
MX2021000977A (es) 2018-07-26 2021-04-12 Sumitomo Pharma Oncology Inc Metodos para tratar enfermedades asociadas con expresion anormal de receptor de activina a tipo 1 (acvr1) e inhibidores de acvr1 para uso en los mismos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01149775A (ja) * 1987-12-07 1989-06-12 Kawaken Fine Chem Co Ltd 光学活性２−メチルピペラジンの製造方法
KR20100017565A (ko) * 2007-05-03 2010-02-16 세파론, 인코포레이티드 (ｒ)-2-메틸피롤리딘 및 (ｓ)-2-메틸피롤리딘 및 이의 타르트레이트 염의 제조 방법
EP2062906A1 (en) 2007-11-22 2009-05-27 Universiteit van Amsterdam Coordination complex system comprising tautomeric ligands
HUE027976T2 (en) 2012-03-06 2016-11-28 Cephalon Inc Condensed ring bicyclic 2,4-diaminopyrimidine derivative as dual ALK and FAK inhibitor

Also Published As

Publication number Publication date
US20170369451A1 (en) 2017-12-28
CA2971415A1 (en) 2016-06-30
ES2707123T3 (es) 2019-04-02
EP3237408A1 (en) 2017-11-01
US10259794B2 (en) 2019-04-16
JP6849594B2 (ja) 2021-03-24
WO2016105529A1 (en) 2016-06-30
EP3237408B1 (en) 2018-10-31
JP2018507173A (ja) 2018-03-15
IL252945B (en) 2020-05-31
IL252945A0 (en) 2017-08-31
HK1244789B (zh) 2019-12-06

Similar Documents

Publication Publication Date Title
MX2017008520A (es) Compuestos de pirimidina fusionada para el tratamiento del virus de inmunodeficiencia humana (vih).
WO2017108723A3 (en) PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS
IL279910A (en) Crystal forms of 5-chloro-ene 4-[2-(dimethylphosphoryl)phenyl]-ene 2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]pyrimidin-2- 4-diamine
PH12016502523A1 (en) Crystalline salts of (s)-6-((1-acetylpiperidin-4-yl)amino)-n-(3-(3,4-dihydroisoquinolin-2(1h)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide
SA518400333B1 (ar) شكل متعدد الأشكال من n- {6-(2-هيدروكسي بروبان-2-يل) -2-[2-(مثيل سلفونيل) إثيل]-2h-إندازول-5-يل}-6-(ثلاثي فلورومثيل) بيريدين-2-كربوكساميد
EA201690303A1 (ru) ПРОИЗВОДНЫЕ ТИЕНО[3,2-d]ПИРИМИДИНОВ ДЛЯ ЛЕЧЕНИЯ ВИРУСНЫХ ИНФЕКЦИЙ
EA201790395A1 (ru) Производные аминотриазина, подходящие для применения в качестве соединений-ингибиторов tank-связывающей киназы
PH12015501363B1 (en) Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity
NZ722624A (en) Fused pyrimidines as inhibitors of p97 complex
NZ727996A (en) Thieno [3,2-d] pyrimidine, furo [3,2,d] pyrimidine, and pyrrolo [3,2-d] pyrimidines useful for treating respiratory syncytial virus infections
JOP20150179B1 (ar) مركبات 6 ، 7 ثاني هيدرو بيرازولو [ 1، 5 الفا ] بيرازين – 4 (5 يد) – اون واستخدامها كمنظمات الوسترية سلبية لمستقبلات ملجور 2
PH12018501641B1 (en) Tlr7 agonist trifluoroacetate salt and crystalline form b thereof, preparation methods and uses
EA201792374A1 (ru) Азабензимидазолы и их применение в качестве модуляторов рецептора ampa
MX2017008430A (es) Métodos para preparar derivados de 2,4-diaminopirimidina bíclica fusionada.
PH12020550703A1 (en) Sulfonamide compounds and use thereof
TR201900735T4 (tr) Yeni kaynaşık imidazobenzotiyazol bileşikleri.
PH12018502246A1 (en) Substituted fused pyrimidinone compounds
NZ630251A (en) Fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor
TWD176852S (zh) 化粧品用座台
IN2013CH05870A (es)

Legal Events

Date Code Title Description
FG Grant or registration